Skip to main navigation
  • Contact Us
  • Careers
  • Press Releases
  • LinkedIn
Go to  Aquestive Therapeutics corporate website
  • About Us
    About Us
    • Executive Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Medicines
  • Pipeline
    Pipeline
    • Anaphylm™
    • Libervant®
  • Technologies
  • Services
  • Our Responsibilities
  • Investors
    Investors
      • Press Releases
      • Events & Presentations
      • Investor FAQs
      • Corporate Governance
      • SEC Filings
      • Stock Information
      • Analyst Coverage
      • Quarterly Results
  • About Us
    • Executive Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Medicines
  • Pipeline
    • Anaphylm™
    • Libervant®
  • Technologies
  • Services
  • Our Responsibilities
  • Investors
    • Home
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Quarterly Results
  • Contact Us
  • Careers
  • Press Releases
  • LinkedIn
Breadcrumb
Home Investors Quarterly Results

Quarterly Results

Show all
  • Recent
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • Archive

2026

Q1

  • Earnings Release
  • Webcast
  • Presentation 945.8 KB

2025

Q4

  • Earnings Release
  • Webcast
  • Presentation 1.3 MB
  • Form 10-K

Q3

  • Earnings Release
  • Webcast
  • Presentation 914.8 KB
  • Form 10-Q

Q2

  • Earnings Release
  • Webcast
  • Presentation 1.5 MB
  • Form 10-Q

Q1

  • Earnings Release
  • Webcast
  • Presentation 708.5 KB
  • Form 10-Q

2024

Q4

  • Earnings Release
  • Webcast
  • Presentation 754.8 KB
  • Form 10-K

Q3

  • Earnings Release
  • Webcast
  • Presentation 829.6 KB
  • Form 10-Q

Q2

  • Earnings Release
  • Webcast
  • Presentation 740.6 KB
  • Form 10-Q

Q1

  • Earnings Release
  • Webcast
  • Presentation 468.7 KB
  • Form 10-Q

2023

Q4

  • Earnings Release
  • Webcast
  • Presentation 597.1 KB
  • Form 10-K

Q3

  • Earnings Release
  • Webcast
  • Presentation 811.2 KB
  • Form 10-Q

Q2

  • Earnings Release
  • Webcast
  • Presentation 809.7 KB
  • Form 10-Q

Q1

  • Earnings Release
  • Webcast
  • Presentation 720.4 KB
  • Form 10-Q

2022

Q4

  • Earnings Release
  • Webcast
  • Presentation 794.4 KB
  • Form 10-K

Q3

  • Earnings Release
  • Webcast
  • Presentation 988.1 KB
  • Form 10-Q

Q2

  • Earnings Release
  • Webcast
  • Presentation 1.2 MB
  • Form 10-Q

Q1

  • Earnings Release
  • Webcast
  • Form 10-Q

Subscribe to our Email Alerts

Receive the latest posters, presentations, and data with our clinical trial portal.

  • Email Alerts
  • Investor Contact
  • Investor FAQs
  • RSS Feeds
Aquestive Therapeutics Logo
LinkedIn 

Advancing medicines to bring meaningful

improvement to patients' lives through

innovative science and delivery technologies

    • Investors
    • Press Releases
    • Careers
    • Pipeline
    • About Us
    • Medicines
    • Technologies
    • Services
    • Our Responsibilities
  • Cookie Settings
  • Privacy Policy
  • Contact Us
  • Privacy Notice for California Residents
  • Terms of Use
  • Do Not Sell or Share My Information

©  Aquestive Therapeutics, Inc. PharmFilm®, Libervant®, and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All rights reserved. All other registered trademarks referenced herein are the property of their respective owners.